GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target
cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.
( Total: 19 Current Stock Recommendations )
Sarepta Therapeutics Inc   (19)
Sell Hold 32% Buy 63%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Hold SRPT
Sarepta Therapeutics Inc (SRPT) rated Neutral by Piper Jaffray
Monday,  Jan 18, 2016  8:25 AM ET

Rating:
Hold SRPT
Sarepta Therapeutics Inc (SRPT) rated Neutral by Piper Jaffray
Friday,  Jan 15, 2016  12:25 PM ET

Rating:
Buy SRPT
up 43.48 %
Sarepta Therapeutics Inc (SRPT) rated Buy by BofA/Merrill
Friday,  Oct 23, 2015  10:25 AM ET

Rating:
Buy SRPT
down 6.83 %

Rating:
Buy SRPT
up 7.37 %

Rating:
Buy SRPT
up 50.14 %

Rating:
Buy SRPT
up 153.00 %

Rating:
Buy SRPT
up 161.02 %

Rating:
Buy SRPT
up 116.94 %

Rating:
Buy SRPT
up 64.90 %

Rating:
Buy SRPT
up 78.20 %

Rating:
Hold SRPT

Your Recent Stocks
SymbolLastChange
SRPT 14.32 down  -60.47 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy